INGENOX Trademark

Trademark Overview


On Friday, May 26, 2023, a trademark application was filed for INGENOX with the United States Patent and Trademark Office. The USPTO has given the INGENOX trademark a serial number of 98015547. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by INGENOX THERAPEUTICS LIMITED. The INGENOX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer

biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and ...
ingenox

General Information


Serial Number98015547
Word MarkINGENOX
Filing DateFriday, May 26, 2023
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7437794
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesEpigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer
Goods and Servicesbiochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 27, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINGENOX THERAPEUTICS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOxford OX44GA
GB

Party NameINGENOX THERAPEUTICS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOxford OX44GA
GB

Party NameINGENOX THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxford OX44GA
GB

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NEW APPLICATION ENTERED
Tuesday, June 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 20, 2024ASSIGNED TO EXAMINER
Tuesday, February 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, March 11, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 13, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 13, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED